Global VEGF Inhibitor Drugs Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global VEGF Inhibitor Drugs Market Size 2017-2028

2.1.2 VEGF Inhibitor Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 VEGF Inhibitor Drugs Segment by Type

2.2.1 Tyrosine Kinase Inhibitors

2.2.2 Monoclonal Antibodies

2.2.3 Others

2.3 VEGF Inhibitor Drugs Market Size by Type

2.3.1 VEGF Inhibitor Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

2.4 VEGF Inhibitor Drugs Segment by Application

2.4.1 Oncology

2.4.2 Ophthalmology

2.4.3 Others

2.5 VEGF Inhibitor Drugs Market Size by Application

2.5.1 VEGF Inhibitor Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

3 VEGF Inhibitor Drugs Market Size by Player

3.1 VEGF Inhibitor Drugs Market Size Market Share by Players

3.1.1 Global VEGF Inhibitor Drugs Revenue by Players (2020-2022)

3.1.2 Global VEGF Inhibitor Drugs Revenue Market Share by Players (2020-2022)

3.2 Global VEGF Inhibitor Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 VEGF Inhibitor Drugs by Regions

4.1 VEGF Inhibitor Drugs Market Size by Regions (2017-2022)

4.2 Americas VEGF Inhibitor Drugs Market Size Growth (2017-2022)

4.3 APAC VEGF Inhibitor Drugs Market Size Growth (2017-2022)

4.4 Europe VEGF Inhibitor Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa VEGF Inhibitor Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas VEGF Inhibitor Drugs Market Size by Country (2017-2022)

5.2 Americas VEGF Inhibitor Drugs Market Size by Type (2017-2022)

5.3 Americas VEGF Inhibitor Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC VEGF Inhibitor Drugs Market Size by Region (2017-2022)

6.2 APAC VEGF Inhibitor Drugs Market Size by Type (2017-2022)

6.3 APAC VEGF Inhibitor Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe VEGF Inhibitor Drugs by Country (2017-2022)

7.2 Europe VEGF Inhibitor Drugs Market Size by Type (2017-2022)

7.3 Europe VEGF Inhibitor Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa VEGF Inhibitor Drugs by Region (2017-2022)

8.2 Middle East & Africa VEGF Inhibitor Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa VEGF Inhibitor Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global VEGF Inhibitor Drugs Market Forecast

10.1 Global VEGF Inhibitor Drugs Forecast by Regions (2023-2028)

10.1.1 Global VEGF Inhibitor Drugs Forecast by Regions (2023-2028)

10.1.2 Americas VEGF Inhibitor Drugs Forecast

10.1.3 APAC VEGF Inhibitor Drugs Forecast

10.1.4 Europe VEGF Inhibitor Drugs Forecast

10.1.5 Middle East & Africa VEGF Inhibitor Drugs Forecast

10.2 Americas VEGF Inhibitor Drugs Forecast by Country (2023-2028)

10.2.1 United States VEGF Inhibitor Drugs Market Forecast

10.2.2 Canada VEGF Inhibitor Drugs Market Forecast

10.2.3 Mexico VEGF Inhibitor Drugs Market Forecast

10.2.4 Brazil VEGF Inhibitor Drugs Market Forecast

10.3 APAC VEGF Inhibitor Drugs Forecast by Region (2023-2028)

10.3.1 China VEGF Inhibitor Drugs Market Forecast

10.3.2 Japan VEGF Inhibitor Drugs Market Forecast

10.3.3 Korea VEGF Inhibitor Drugs Market Forecast

10.3.4 Southeast Asia VEGF Inhibitor Drugs Market Forecast

10.3.5 India VEGF Inhibitor Drugs Market Forecast

10.3.6 Australia VEGF Inhibitor Drugs Market Forecast

10.4 Europe VEGF Inhibitor Drugs Forecast by Country (2023-2028)

10.4.1 Germany VEGF Inhibitor Drugs Market Forecast

10.4.2 France VEGF Inhibitor Drugs Market Forecast

10.4.3 UK VEGF Inhibitor Drugs Market Forecast

10.4.4 Italy VEGF Inhibitor Drugs Market Forecast

10.4.5 Russia VEGF Inhibitor Drugs Market Forecast

10.5 Middle East & Africa VEGF Inhibitor Drugs Forecast by Region (2023-2028)

10.5.1 Egypt VEGF Inhibitor Drugs Market Forecast

10.5.2 South Africa VEGF Inhibitor Drugs Market Forecast

10.5.3 Israel VEGF Inhibitor Drugs Market Forecast

10.5.4 Turkey VEGF Inhibitor Drugs Market Forecast

10.5.5 GCC Countries VEGF Inhibitor Drugs Market Forecast

10.6 Global VEGF Inhibitor Drugs Forecast by Type (2023-2028)

10.7 Global VEGF Inhibitor Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer VEGF Inhibitor Drugs Product Offered

11.1.3 Pfizer VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Novartis AG

11.2.1 Novartis AG Company Information

11.2.2 Novartis AG VEGF Inhibitor Drugs Product Offered

11.2.3 Novartis AG VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis AG Main Business Overview

11.2.5 Novartis AG Latest Developments

11.3 GlaxoSmithKline plc

11.3.1 GlaxoSmithKline plc Company Information

11.3.2 GlaxoSmithKline plc VEGF Inhibitor Drugs Product Offered

11.3.3 GlaxoSmithKline plc VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GlaxoSmithKline plc Main Business Overview

11.3.5 GlaxoSmithKline plc Latest Developments

11.4 Sanofi

11.4.1 Sanofi Company Information

11.4.2 Sanofi VEGF Inhibitor Drugs Product Offered

11.4.3 Sanofi VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sanofi Main Business Overview

11.4.5 Sanofi Latest Developments

11.5 AstraZeneca plc

11.5.1 AstraZeneca plc Company Information

11.5.2 AstraZeneca plc VEGF Inhibitor Drugs Product Offered

11.5.3 AstraZeneca plc VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 AstraZeneca plc Main Business Overview

11.5.5 AstraZeneca plc Latest Developments

11.6 Bristol-Myers-Squibb Company

11.6.1 Bristol-Myers-Squibb Company Company Information

11.6.2 Bristol-Myers-Squibb Company VEGF Inhibitor Drugs Product Offered

11.6.3 Bristol-Myers-Squibb Company VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bristol-Myers-Squibb Company Main Business Overview

11.6.5 Bristol-Myers-Squibb Company Latest Developments

11.7 Genentech, Inc. (Roche)

11.7.1 Genentech, Inc. (Roche) Company Information

11.7.2 Genentech, Inc. (Roche) VEGF Inhibitor Drugs Product Offered

11.7.3 Genentech, Inc. (Roche) VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Genentech, Inc. (Roche) Main Business Overview

11.7.5 Genentech, Inc. (Roche) Latest Developments

11.8 Merck & Co., Inc.

11.8.1 Merck & Co., Inc. Company Information

11.8.2 Merck & Co., Inc. VEGF Inhibitor Drugs Product Offered

11.8.3 Merck & Co., Inc. VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Merck & Co., Inc. Main Business Overview

11.8.5 Merck & Co., Inc. Latest Developments

11.9 Bayer AG

11.9.1 Bayer AG Company Information

11.9.2 Bayer AG VEGF Inhibitor Drugs Product Offered

11.9.3 Bayer AG VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bayer AG Main Business Overview

11.9.5 Bayer AG Latest Developments

11.10 Eli Lilly & Company

11.10.1 Eli Lilly & Company Company Information

11.10.2 Eli Lilly & Company VEGF Inhibitor Drugs Product Offered

11.10.3 Eli Lilly & Company VEGF Inhibitor Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eli Lilly & Company Main Business Overview

11.10.5 Eli Lilly & Company Latest Developments

12 Research Findings and Conclusion

Table 1. VEGF Inhibitor Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Tyrosine Kinase Inhibitors

Table 3. Major Players of Monoclonal Antibodies

Table 4. Major Players of Others

Table 5. VEGF Inhibitor Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global VEGF Inhibitor Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

Table 8. VEGF Inhibitor Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global VEGF Inhibitor Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

Table 11. Global VEGF Inhibitor Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global VEGF Inhibitor Drugs Revenue Market Share by Player (2020-2022)

Table 13. VEGF Inhibitor Drugs Key Players Head office and Products Offered

Table 14. VEGF Inhibitor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global VEGF Inhibitor Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global VEGF Inhibitor Drugs Market Size Market Share by Regions (2017-2022)

Table 19. Americas VEGF Inhibitor Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas VEGF Inhibitor Drugs Market Size Market Share by Country (2017-2022)

Table 21. Americas VEGF Inhibitor Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

Table 23. Americas VEGF Inhibitor Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

Table 25. APAC VEGF Inhibitor Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC VEGF Inhibitor Drugs Market Size Market Share by Region (2017-2022)

Table 27. APAC VEGF Inhibitor Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

Table 29. APAC VEGF Inhibitor Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

Table 31. Europe VEGF Inhibitor Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe VEGF Inhibitor Drugs Market Size Market Share by Country (2017-2022)

Table 33. Europe VEGF Inhibitor Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

Table 35. Europe VEGF Inhibitor Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa VEGF Inhibitor Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa VEGF Inhibitor Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa VEGF Inhibitor Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of VEGF Inhibitor Drugs

Table 44. Key Market Challenges & Risks of VEGF Inhibitor Drugs

Table 45. Key Industry Trends of VEGF Inhibitor Drugs

Table 46. Global VEGF Inhibitor Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global VEGF Inhibitor Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global VEGF Inhibitor Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global VEGF Inhibitor Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global VEGF Inhibitor Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global VEGF Inhibitor Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 52. Pfizer Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 53. Pfizer VEGF Inhibitor Drugs Product Offered

Table 54. Pfizer VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Pfizer Main Business

Table 56. Pfizer Latest Developments

Table 57. Novartis AG Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 58. Novartis AG VEGF Inhibitor Drugs Product Offered

Table 59. Novartis AG Main Business

Table 60. Novartis AG VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Novartis AG Latest Developments

Table 62. GlaxoSmithKline plc Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 63. GlaxoSmithKline plc VEGF Inhibitor Drugs Product Offered

Table 64. GlaxoSmithKline plc Main Business

Table 65. GlaxoSmithKline plc VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. GlaxoSmithKline plc Latest Developments

Table 67. Sanofi Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 68. Sanofi VEGF Inhibitor Drugs Product Offered

Table 69. Sanofi Main Business

Table 70. Sanofi VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Sanofi Latest Developments

Table 72. AstraZeneca plc Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 73. AstraZeneca plc VEGF Inhibitor Drugs Product Offered

Table 74. AstraZeneca plc Main Business

Table 75. AstraZeneca plc VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. AstraZeneca plc Latest Developments

Table 77. Bristol-Myers-Squibb Company Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 78. Bristol-Myers-Squibb Company VEGF Inhibitor Drugs Product Offered

Table 79. Bristol-Myers-Squibb Company Main Business

Table 80. Bristol-Myers-Squibb Company VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Bristol-Myers-Squibb Company Latest Developments

Table 82. Genentech, Inc. (Roche) Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 83. Genentech, Inc. (Roche) VEGF Inhibitor Drugs Product Offered

Table 84. Genentech, Inc. (Roche) Main Business

Table 85. Genentech, Inc. (Roche) VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Genentech, Inc. (Roche) Latest Developments

Table 87. Merck & Co., Inc. Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 88. Merck & Co., Inc. VEGF Inhibitor Drugs Product Offered

Table 89. Merck & Co., Inc. Main Business

Table 90. Merck & Co., Inc. VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Merck & Co., Inc. Latest Developments

Table 92. Bayer AG Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 93. Bayer AG VEGF Inhibitor Drugs Product Offered

Table 94. Bayer AG Main Business

Table 95. Bayer AG VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Bayer AG Latest Developments

Table 97. Eli Lilly & Company Details, Company Type, VEGF Inhibitor Drugs Area Served and Its Competitors

Table 98. Eli Lilly & Company VEGF Inhibitor Drugs Product Offered

Table 99. Eli Lilly & Company Main Business

Table 100. Eli Lilly & Company VEGF Inhibitor Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Eli Lilly & Company Latest Developments

List of Figures

Figure 1. VEGF Inhibitor Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global VEGF Inhibitor Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global VEGF Inhibitor Drugs Market Size Market Share by Type in 2021

Figure 7. VEGF Inhibitor Drugs in Oncology

Figure 8. Global VEGF Inhibitor Drugs Market: Oncology (2017-2022) & ($ Millions)

Figure 9. VEGF Inhibitor Drugs in Ophthalmology

Figure 10. Global VEGF Inhibitor Drugs Market: Ophthalmology (2017-2022) & ($ Millions)

Figure 11. VEGF Inhibitor Drugs in Others

Figure 12. Global VEGF Inhibitor Drugs Market: Others (2017-2022) & ($ Millions)

Figure 13. Global VEGF Inhibitor Drugs Market Size Market Share by Application in 2021

Figure 14. Global VEGF Inhibitor Drugs Revenue Market Share by Player in 2021

Figure 15. Global VEGF Inhibitor Drugs Market Size Market Share by Regions (2017-2022)

Figure 16. Americas VEGF Inhibitor Drugs Market Size 2017-2022 ($ Millions)

Figure 17. APAC VEGF Inhibitor Drugs Market Size 2017-2022 ($ Millions)

Figure 18. Europe VEGF Inhibitor Drugs Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa VEGF Inhibitor Drugs Market Size 2017-2022 ($ Millions)

Figure 20. Americas VEGF Inhibitor Drugs Value Market Share by Country in 2021

Figure 21. Americas VEGF Inhibitor Drugs Consumption Market Share by Type in 2021

Figure 22. Americas VEGF Inhibitor Drugs Market Size Market Share by Application in 2021

Figure 23. United States VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC VEGF Inhibitor Drugs Market Size Market Share by Region in 2021

Figure 28. APAC VEGF Inhibitor Drugs Market Size Market Share by Application in 2021

Figure 29. China VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. India VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe VEGF Inhibitor Drugs Market Size Market Share by Country in 2021

Figure 36. Europe VEGF Inhibitor Drugs Market Size Market Share by Type in 2021

Figure 37. Europe VEGF Inhibitor Drugs Market Size Market Share by Application in 2021

Figure 38. Germany VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. France VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa VEGF Inhibitor Drugs Market Size Market Share by Application in 2021

Figure 46. Egypt VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country VEGF Inhibitor Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 52. APAC VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 53. Europe VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 55. United States VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 56. Canada VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 57. Mexico VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Brazil VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 59. China VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Japan VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Korea VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 63. India VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Australia VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Germany VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 66. France VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 67. UK VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Italy VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Russia VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 70. Spain VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 71. Egypt VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 72. South Africa VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Israel VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 74. Turkey VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries VEGF Inhibitor Drugs Market Size 2023-2028 ($ Millions)